Chirag Patel
Interventional Cardiology · Houston, TXNPI 1790212850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,542 of the $3,052 with a category attached, or 83.3%. It is spread thinly across 22 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,148, 2.8 times the $413 reported in 2019. That places this record below the midpoint for interventional cardiology clinicians in TX, where the typical reported total is $9,094.
Across 86 payments — averaging $35.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$565
- Medtronic$412
- Boston Scientific$373
- Edwards Lifesciences$304
- Abbott$208
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$208
- plus $983 from 16 others
What the payments were for
- Food & beverage$2,54283%
- Education$51017%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 20 | $565 |
| Medtronic | 12 | $412 |
| Boston Scientific | 5 | $373 |
| Edwards Lifesciences | 3 | $304 |
| Abbott | 1 | $208 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $208 |
| Bristol Myers Squibb | 10 | $162 |
| Stryker | 1 | $154 |
| Kerecis Limited | 1 | $141 |
| Abiomed | 2 | $134 |
| Novartis | 4 | $75 |
| E.r. Squibb & Sons, L.L.C. | 3 | $48 |
| Amneal Pharmaceuticals LLC | 3 | $43 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $38 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $31 |
| Terumo Medical Corporation | 1 | $29 |
| Johnson & Johnson | 2 | $28 |
| Lantheus Medical Imaging, Inc. | 1 | $27 |
| AstraZeneca | 1 | $22 |
| Pfizer | 1 | $20 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| CSL Behring | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,052 in reported general payments places this provider in the 15th percentile of 686 interventional cardiology providers in Texas.
Other interventional cardiology in Houston
- Juan GranadaHouston$4.1M
- John IsaacHouston$1.8M
- Sanjay KunapuliHouston$267K
- Michele SartoriHouston$266K
- Abhijeet DhobleHouston$161K
- Amir KashaniHouston$148K
- Dhaval ParekhHouston$137K
- Neal KleimanHouston$118K
- Mehran MassumiHouston$114K
- Eduardo HernandezHouston$112K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.